Page 4 - Whrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Whrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Whrx Today - Breaking & Trending Today

Héroux-Devtek (TSE:HRX) Given New C$18.00 Price Target at Scotiabank

Héroux-Devtek (TSE:HRX – Get Rating) had its price target upped by Scotiabank from C$17.00 to C$18.00 in a research report report published on Friday, BayStreet.CA reports. HRX has been the topic of a number of other reports. TD Securities downgraded shares of Héroux-Devtek from a buy rating to a hold rating and reduced their price […] ....

Raymond James , National Bankshares , Devtek Inc , Devtek Company Profile , Get Rating , Devtek Price , Devtek Company , Devtek Daily , Héroux Devtek , Tse Hrx , Boost Price Target ,

Héroux-Devtek (TSE:HRX) PT Raised to C$18.00 at TD Securities

Héroux-Devtek (TSE:HRX – Get Rating) had its target price hoisted by stock analysts at TD Securities from C$16.50 to C$18.00 in a research report issued on Friday, BayStreet.CA reports. The firm presently has a “hold” rating on the stock. TD Securities’ target price indicates a potential upside of 29.40% from the company’s previous close. A […] ....

Raymond James , Devtek Inc , National Bankshares , Get Rating , Devtek Stock , Devtek Daily , Héroux Devtek , Tse Hrx , Boost Price Target , Td Securities ,

IIROC Trade Resumption - PHRX | MarketScreener

VANCOUVER, BC, May 17, 2023 /CNW/ - Trading resumes in:
Company: Pharmadrug Inc.
CSE Symbol: PHRX
All Issues: Yes
Resumption : 11:15 AM
IIROC can make a decision to impose a temporary. | May 17, 2023 ....

British Columbia , Investment Industry Regulatory Organization Of Canada , Pharmadrug Inc , Industry Regulatory Organization , Canada Newswire , Pharmadrug Inc Stock Exchange , Press Release , Mpose Phrx Ca71716w1059 ,

HepaRegeniX reports positive topline results of its Phase 1 Clinical Trial of HRX-0215, a First-In-Class MKK4 inhibitor

12.05.2022 HepaRegeniX reports positive topline results of its Phase 1 Clinical Trial of HRX-0215, a First-In-Class MKK4 inhibitor | HRX | Liver | Liverregeneration | MKK4 | ....

United Kingdom , Katja Arnold , Andreas Jungfer , Shaun Brown , Wolfgang Albrecht , Mc Services , Heparegenix Gmbh , Mitogen Activated Protein , Managing Director ,

Initial public offerings scheduled to debut next week

NEW YORK (AP) The following is a list of initial public offerings planned for the. ....

United Kingdom , United States , Goldman Sachs Morgan Stanley , Morgan Stanley Bof , Theseus Pharmaceuticals , Health Fitness , Oppenheimer Co Ladenburg Thalmann , Life Time Group Holdings , Aegis Capital Corp , Proposed Nasdaq , Aegis Capital , Time Group Holdings , Oppenheimer Amp , Kansas City , Yngn Menlo Park , New York , C Complete State National , Renaissance Capital , Roth Capital , Morgan Stanley , The Benchmark Company , Pinoff Of Biofrontera Ag , Ladenburg Thalmann , Fit Health Amp , Bofa Securities , Goldman Sachs ,